- Johnson & Johnson (JNJ) has become the latest major pharmaceutical firm to say that it will make more data from its clinical trials available to researchers.
- JNJ has signed an agreement with Yale University to share information about hundreds of drugs and other products.
- Yale will vet requests from researchers without input from J&J.
- Part of the idea is to increase the credibility of the data. "The medical scientific community and population at large want to have more transparency on what we do," says J&J's Paul Stoffels. "To get really credible, we took the leap."
- Other big pharma companies to pledge to release data in the past year include GSK and Roche. (PR)